Oertle, S., H. Mauron, and P. Villiger. “Inhibition of the TNF-Pathway: Use of Infliximab and Etanercept As Remission-Inducing Agents in Cases of Therapy-Resistant Chronic Inflammatory Disorders”. Swiss Medical Weekly, vol. 132, no. 2930, July 2002, pp. 414-, doi:10.4414/smw.2002.10031.